Mounjaro 5 MG/0.5 ML pen 0.5ML

Ended Awarded Last action

Contract number
SPE2DR26FNR5R
Awardee
Awarding agency
Obligated
$21,839

Award facts

Contract value 100% obligated
$21,839.24 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Mounjaro 5 mg/0.5 ml pens with a ceiling value of $21,839.24. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under full and open competition. The work is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 14, 2026. This delivery order is issued under a larger Indefinite Delivery Contract vehicle held by parent company Cencora, Inc. (doing business as AmerisourceBergen) with the DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support contract enabling the supply of brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency. The company maintains an extensive portfolio of federal contract awards for pharmaceutical products and medical supplies across diverse therapeutic areas. The delivery order for Mounjaro, a diabetes medication, exemplifies the contractor's role in supplying essential prescription medications to support military healthcare programs and other federal medical institutions worldwide. As a subsidiary of Cencora, Inc., the company competes on a full and open basis and has demonstrated consistent capability to efficiently fulfill government contracts for essential pharmaceutical and medical commodities required by military treatment facilities and other federal healthcare entities.

Quick answers

Who was awarded contract SPE2DR26FNR5R?

SPE2DR26FNR5R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.

How much is contract SPE2DR26FNR5R worth?

The government has obligated $21,839 on SPE2DR26FNR5R.

Is contract SPE2DR26FNR5R an order under another contract?

Yes. SPE2DR26FNR5R is a delivery order under SPE2DR25D1021, an indefinite delivery contract.

Was contract SPE2DR26FNR5R competed?

The extent of competition for SPE2DR26FNR5R was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award